Latest news with #ALNT
Yahoo
16-05-2025
- Business
- Yahoo
1 Cash-Producing Stock with Competitive Advantages and 2 to Keep Off Your Radar
While strong cash flow is a key indicator of stability, it doesn't always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning. Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here is one cash-producing company that leverages its financial strength to beat its competitors and two that may struggle to keep up. Trailing 12-Month Free Cash Flow Margin: 7.5% Founded in 1962, Allient (NASDAQ:ALNT) develops and manufactures precision and specialty-controlled motion components and systems. Why Is ALNT Risky? Annual sales declines of 1.7% for the past two years show its products and services struggled to connect with the market during this cycle Projected sales growth of 3.7% for the next 12 months suggests sluggish demand Earnings per share decreased by more than its revenue over the last two years, partly because it diluted shareholders Allient's stock price of $33 implies a valuation ratio of 17.2x forward P/E. To fully understand why you should be careful with ALNT, check out our full research report (it's free). Trailing 12-Month Free Cash Flow Margin: 1.5% Based in Pittsburgh, WESCO (NYSE:WCC) provides electrical, industrial, and communications products and augments them with services such as supply chain management. Why Are We Cautious About WCC? Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion Earnings per share have dipped by 15.3% annually over the past two years, which is concerning because stock prices follow EPS over the long term Free cash flow margin shrank by 3.4 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive WESCO is trading at $171.24 per share, or 12.1x forward P/E. Read our free research report to see why you should think twice about including WCC in your portfolio, it's free. Trailing 12-Month Free Cash Flow Margin: 14.4% Based in Texas and founded over a century ago, Lennox (NYSE:LII) is a climate control solutions company offering heating, ventilation, air conditioning, and refrigeration (HVACR) goods. Why Is LII Interesting? Operating profits increased over the last five years as the company gained some leverage on its fixed costs and became more efficient Earnings per share grew by 24.3% annually over the last two years and trumped its peers Industry-leading 50.4% return on capital demonstrates management's skill in finding high-return investments At $594.22 per share, Lennox trades at 25x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it's free. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Sign in to access your portfolio
Yahoo
08-05-2025
- Business
- Yahoo
Allient: Q1 Earnings Snapshot
AMHERST, N.Y. (AP) — AMHERST, N.Y. (AP) — Allient Inc. (ALNT) on Wednesday reported first-quarter profit of $3.6 million. On a per-share basis, the Amherst, New York-based company said it had profit of 21 cents. Earnings, adjusted for amortization costs and restructuring costs, came to 46 cents per share. The motion control product maker posted revenue of $132.8 million in the period. Allient shares have dropped nearly 9% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $22.12, a fall of 30% in the last 12 months. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ALNT at
Yahoo
02-05-2025
- Business
- Yahoo
1 Stock Under $50 with Solid Fundamentals and 2 to Keep Off Your Radar
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market. This is precisely where StockStory comes in - we do the heavy lifting to identify companies with solid fundamentals so you can invest with confidence. That said, here is one stock under $50 with huge potential and two best left ignored. Share Price: $21.63 Founded in 1962, Allient (NASDAQ:ALNT) develops and manufactures precision and specialty-controlled motion components and systems. Why Should You Dump ALNT? Annual revenue growth of 2.6% over the last two years was below our standards for the industrials sector Projected sales are flat for the next 12 months, implying demand will slow from its two-year trend Performance over the past five years was negatively impacted by new share issuances as its earnings per share were flat while its revenue grew Allient is trading at $21.63 per share, or 11.9x forward P/E. Check out our free in-depth research report to learn more about why ALNT doesn't pass our bar. Share Price: $49.60 With roots dating back to 1887 and a transformative merger in 1989 that gave the company its current name, Bristol-Myers Squibb (NYSE:BMY) discovers, develops, and markets prescription medications for serious diseases including cancer, blood disorders, immunological conditions, and cardiovascular diseases. Why Are We Cautious About BMY? Sizable revenue base leads to growth challenges as its 1.9% annual revenue increases over the last two years fell short of other healthcare companies Sales are projected to tank by 4.4% over the next 12 months as demand evaporates Waning returns on capital from an already weak starting point displays the inefficacy of management's past and current investment decisions Bristol-Myers Squibb's stock price of $49.60 implies a valuation ratio of 7.5x forward P/E. Dive into our free research report to see why there are better opportunities than BMY. Share Price: $31.93 Founded in 2011 after the co-founders met at NYC Disrupt Hackathon, Braze (NASDAQ:BRZE) is a customer engagement software platform that allows brands to connect with customers through data-driven and contextual marketing campaigns. Why Do We Like BRZE? Customers view its software as mission-critical to their operations as its ARR has averaged 26.8% growth over the last year High switching costs and customer loyalty are evident in its net revenue retention rate of 114% Operating margin improvement of 10.1 percentage points over the last year demonstrates its ability to scale efficiently At $31.93 per share, Braze trades at 4.7x forward price-to-sales. Is now the time to initiate a position? Find out in our full research report, it's free. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Comfort Systems (+751% five-year return). Find your next big winner with StockStory today for free. Sign in to access your portfolio
Yahoo
29-04-2025
- Business
- Yahoo
3 Reasons to Avoid ALNT and 1 Stock to Buy Instead
While the broader market has struggled with the S&P 500 down 5% since October 2024, Allient has surged ahead as its stock price has climbed by 19.5% to $21.01 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation. Is there a buying opportunity in Allient, or does it present a risk to your portfolio? Check out our in-depth research report to see what our analysts have to say, it's free. We're happy investors have made money, but we're cautious about Allient. Here are three reasons why we avoid ALNT and a stock we'd rather own. A company's long-term sales performance can indicate its overall quality. Any business can have short-term success, but a top-tier one grows for years. Regrettably, Allient's sales grew at a mediocre 7.4% compounded annual growth rate over the last five years. This was below our standard for the industrials sector. Forecasted revenues by Wall Street analysts signal a company's potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite. Over the next 12 months, sell-side analysts expect Allient's revenue to stall, a slight deceleration versus its 2.6% annualized growth for the past two years. This projection doesn't excite us and suggests its products and services will see some demand headwinds. Analyzing the long-term change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions. Allient's flat EPS over the last five years was below its 7.4% annualized revenue growth. This tells us the company became less profitable on a per-share basis as it expanded. We see the value of companies helping their customers, but in the case of Allient, we're out. With its shares beating the market recently, the stock trades at 11.7× forward price-to-earnings (or $21.01 per share). This valuation is reasonable, but the company's shaky fundamentals present too much downside risk. There are better investments elsewhere. We'd suggest looking at a safe-and-steady industrials business benefiting from an upgrade cycle. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Comfort Systems (+751% five-year return). Find your next big winner with StockStory today for free. Sign in to access your portfolio
